Sanofi to Acquire 26.4% Stake in Cheplapharm

MT newswire2026/09/14 13:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:52 AM EDT, 09/14/2026 (MT Newswires) -- Sanofi (SNY) will acquire a 26.4% stake in Cheplapharm as part of a partnership agreement that would transfer 20 established medicines and three manufacturing sites to the German pharmaceutical company, the companies said Monday. Under the agreement, the commercial transfer of the mature medicine portfolio is slated to begin in Q1 of 2027, followed by the transfer of three manufacturing sites located in Hungary, France, and Singapore, according to a statement. The transaction, anticipated to close in Q3 of 2027, is not expected to affect Sanofi's 2026 guidance, the companies said. Sanofi shares were up 1.3% in early Monday trading. Price: 43.32, Change: +0.55, Percent Change: +1.29

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The Manufacturing Purchasing Managers' Index (PMI) released by the Institute for Supply Management (ISM) in the United States rose by 1 point in October to reach 55.5, marking the second highest reading in more than four years and exceeding the market expectation of 54.7. The production index recorded its best performance since the end of 2021, while the new orders index, a key indicator of demand, also reached its highest level since July.

华尔街见闻•2026/11/02 18:26